Cui Jingrong Jean
Director at Turning Point Therapeutics, Inc.
- Sold, on record
- $40.5M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Jun 9, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Turning Point Therapeutics, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedApr 8, 2020 2020
Sold 55,500 shares at $44.87 ($2.5M)
Cui Jingrong Jean, Director
Sold 7.1% of holdings ($35.1M position)726,591 shares left1.6x usual sizeFiling
- 2 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedApr 13, 2020 +5 days
Sold 12,208 shares at $47.60 ($581k)
Cui Jingrong Jean, Director
Sold 1.7% of holdings ($34.6M position)714,383 shares left0.3x usual sizeFiling
- 3 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedApr 24, 2020 +11 days
Sold 21,000 shares at $51.57 ($1.1M)
Cui Jingrong Jean, Director
Sold 2.9% of holdings ($36.8M position)693,383 shares left0.6x usual sizeFiling
- 4 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedMay 7, 2020 +13 days
Sold 55,500 shares at $53.27 ($3M)
Cui Jingrong Jean, Director
Sold 8% of holdings ($36.9M position)637,883 shares left1.7x usual sizeFiling
- 5 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedMay 8, 2020 +1 day
Sold 11,500 shares at $53.86 ($619k)
Cui Jingrong Jean, Director
Sold 1.8% of holdings ($34.4M position)626,383 shares left0.3x usual sizeFiling
- 6 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedMay 21, 2020 +13 days
Sold 21,000 shares at $59.18 ($1.2M)
Cui Jingrong Jean, Director
Sold 3.4% of holdings ($37.1M position)605,383 shares left0.6x usual sizeFiling
- 7 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedJun 8, 2020 +18 days
Sold 55,500 shares at $64.16 ($3.6M)
Cui Jingrong Jean, Director
Sold 9.2% of holdings ($38.8M position)549,883 shares left1.7x usual sizeFiling
- 8 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedJun 9, 2020 +1 day
Sold 9,500 shares at $65.81 ($625k)
Cui Jingrong Jean, Director
Sold 1.7% of holdings ($36.2M position)540,383 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2020 | Jun 10, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 9,500 | $625k | 1.7% | Plan not stated | SEC |
| Jun 8, 2020 | Jun 8, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 55,500 | $3.6M | 9.2% | Plan not stated | SEC |
| May 21, 2020 | May 21, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 21,000 | $1.2M | 3.4% | Plan not stated | SEC |
| May 8, 2020 | May 12, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 11,500 | $619k | 1.8% | Plan not stated | SEC |
| May 7, 2020 | May 7, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 55,500 | $3M | 8.0% | Plan not stated | SEC |
| Apr 24, 2020 | Apr 24, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 21,000 | $1.1M | 2.9% | Plan not stated | SEC |
| Apr 13, 2020 | Apr 13, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 12,208 | $581k | 1.7% | Plan not stated | SEC |
| Apr 8, 2020 | Apr 8, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 55,500 | $2.5M | 7.1% | Plan not stated | SEC |
| Mar 26, 2020 | Mar 27, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 11,500 | $529k | 1.4% | Plan not stated | SEC |
| Mar 25, 2020 | Mar 25, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 31,792 | $1.4M | 3.9% | Plan not stated | SEC |
| Mar 12, 2020 | Mar 12, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 44,000 | $1.8M | 5.1% | Plan not stated | SEC |
| Feb 26, 2020 | Feb 26, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 21,000 | $1.1M | 2.4% | Plan not stated | SEC |
| Feb 13, 2020 | Feb 14, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 11,500 | $711k | 1.5% | Plan not stated | SEC |
| Feb 12, 2020 | Feb 12, 2020 | Turning Point Therapeutics, Inc. | Director | Form 4 sale | 55,500 | $3.6M | 6.5% | Plan not stated | SEC |
| Jan 29, 2020 | Jan 29, 2020 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 21,000 | $1.2M | 2.4% | Plan not stated | SEC |
| Jan 15, 2020 | Jan 17, 2020 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 11,500 | $611k | 1.3% | Plan not stated | SEC |
| Jan 14, 2020 | Jan 14, 2020 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 55,500 | $3M | 5.9% | Plan not stated | SEC |
| Dec 20, 2019 | Dec 20, 2019 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 48,500 | $3M | 4.9% | Plan not stated | SEC |
| Dec 17, 2019 | Dec 17, 2019 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 41,500 | $2.4M | 4.0% | Plan not stated | SEC |
| Dec 12, 2019 | Dec 12, 2019 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 34,500 | $1.9M | 3.3% | Plan not stated | SEC |
| Dec 9, 2019 | Dec 9, 2019 | Turning Point Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 118,500 | $6.1M | 10.0% | Plan not stated | SEC |